99% Savings - Buy Just @1 Rs X
StayHappi Voglibose + Metformin + Glimepride Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of StayHappi Voglibose + Metformin + Glimepride Tablet safe for pregnant women?
StayHappi Voglibose + Metformin + Glimepride Tablet may have some side effects during pregnancy. Pregnant women should discontinue the use of StayHappi Voglibose + Metformin + Glimepride Tablet, and talk to their doctor, if they notice any discomfort.
Is the use of StayHappi Voglibose + Metformin + Glimepride Tablet safe during breastfeeding?
Breastfeeding women can safely use StayHappi Voglibose + Metformin + Glimepride Tablet.
What is the effect of StayHappi Voglibose + Metformin + Glimepride Tablet on the Kidneys?
Kidney can be affected by StayHappi Voglibose + Metformin + Glimepride Tablet. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of StayHappi Voglibose + Metformin + Glimepride Tablet on the Liver?
There may be an adverse effect on the liver after taking StayHappi Voglibose + Metformin + Glimepride Tablet. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of StayHappi Voglibose + Metformin + Glimepride Tablet on the Heart?
There may be an adverse effect on the heart after taking StayHappi Voglibose + Metformin + Glimepride Tablet. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
StayHappi Voglibose + Metformin + Glimepride Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Unknown
If you are suffering from any of the following diseases, you should not take StayHappi Voglibose + Metformin + Glimepride Tablet unless your doctor advises you to do so -
Is this StayHappi Voglibose + Metformin + Glimepride Tablet habit forming or addictive?
No, you will not get addicted to StayHappi Voglibose + Metformin + Glimepride Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking StayHappi Voglibose + Metformin + Glimepride Tablet as it does not make you drowsy.
Is it safe?
Yes, but consume StayHappi Voglibose + Metformin + Glimepride Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, StayHappi Voglibose + Metformin + Glimepride Tablet is not used to treat mental disorders.
Interaction between Food and StayHappi Voglibose + Metformin + Glimepride Tablet
Taking StayHappi Voglibose + Metformin + Glimepride Tablet with food does not cause any problems.
Interaction between Alcohol and StayHappi Voglibose + Metformin + Glimepride Tablet
Taking alcohol with StayHappi Voglibose + Metformin + Glimepride Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277